跳至主要内容
临床试验/EUCTR2015-000051-24-FI
EUCTR2015-000051-24-FI进行中(未招募)不适用

The pharmacokinetics and –genomics of remifentanil, and its effects on the depth-of-anaesthesia monitors and the protein synthesis in children.

Klaus Olkkola/University of Helsinki0 个研究点开始时间: 2015年1月23日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patient is 3-15 years old (body weight (15-61 kg). Patients ASA class is 1-2. Patient comes to an elective surgery which necessitates general anesthesia. Operation time is appr. 1.5-6 hours
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patient has a disease or trauma affecting the state of consciousnes or encephaloelectrogram measurement. Patient comes to a head or neck surgery. Anaesthesia cannot be induced via intravenous route. The researchers cannot place the second iv-cannula. Muscle relaxant is needed. Patient or his/her guardians refuse to take part in the study

研究者

发起方
Klaus Olkkola/University of Helsinki

相似试验